Detail page

Knowledge Web

Person

Gerhard Gründer

Psychiater

Name	Gerhard Gründer
Place	Aachen (Wirkungsort) Deutschland
Gender	männlich
Academic degree	Prof. Dr.
Profession	Psychiater (characteristic profession) Psychotherapeut
Variant	G. Gründer
Related	Universitätsklinikum Aachen
Further information	seit 01/2018 Abteilungsleiter für Molekulares Neuroimaging im Zentralinstitut für Seelische Gesundheit Mannheim sowie Professor für Molekulares Neuroimaging an der Medizinischen Fakultät Mannheim der Universität Heidelberg
Record type	Person
GND-Identifier	1078251037
Record ID	1078251037
Involved in show all Psychopharmaka absetzen? : warum, wann und wie? Pharmakotherapie, Psychotherapie oder „Superplacebos“? : Wirkmechanismen der Therapie mit Psychedelika Ermittlung eines therapeutischen Referenzbereiches für Escitalopram Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: results of the COMBINE-study Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: results of the COMBINE-study Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ) Therapeutic reference range for olanzapine in schizophrenia revised Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI How to find and validate therapeutic reference ranges for psychotropic drugs Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia Sind Psychedelika schnell wirksame Antidepressiva? Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial How do we want to live? : we decide ourselves about our future How Do We Want to Live? : We Decide Ourselves About Our Future Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors Psychopharmaka absetzen? Warum, wann und wie? The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia Therapeutic reference range for aripiprazole in schizophrenia revised: a systematic review and metaanalysis Therapeutic reference range for aripiprazole in schizophrenia revised: a systematic review and metaanalysis An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions The Potential Role of Psychedelic Drugs in Mental Health Care of the Future Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping Psychopharmaka absetzen? Warum, wann und wie? Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring Sample Treatment Goals for Patients with Schizophrenia — A Narrative Review of Physician and Patient Perspectives Wie wollen wir leben? : über unsere Zukunft entscheiden wir selbst Wie wollen wir leben? : Über unsere Zukunft entscheiden wir selbst A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database Pharmacokinetic correlates of venlafaxine: associated adverse reactions The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM) : DGN-Handlungsempfehlung (S1-Leitlinie) Pocket Guide Psychopharmaka von A bis Z Pocket Guide Psychopharmaka von A bis Z Comprehensive Measurements of Intrauterine and Postnatal Exposure to Lamotrigine Antidepressants in breast milk; comparative analysis of excretion ratios The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia Peripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine Kompendium der psychiatrischen Pharmakotherapie Kompendium der Psychiatrischen Pharmakotherapie Pocket Guide Psychopharmaka von A bis Z Pocket Guide Psychopharmaka von A bis Z Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns Präferenz von Zielparametern bei der Behandlung der Depression : Ergebnisse einer Delphi-Panel-Erhebung Pharmacokinetic patterns of risperidone-associated adverse drug reactions Dorsch – Lexikon der Psychotherapie und Psychopharmakotherapie Molecular Imaging in the Clinical Neurosciences Kompendium der psychiatrischen Pharmakotherapie Kompendium der Psychiatrischen Pharmakotherapie Pocket Guide Psychopharmaka von A bis Z

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Gerhard Gründer

Psychopharmaka absetzen? : warum, wann und wie?

Pharmakotherapie, Psychotherapie oder „Superplacebos“? : Wirkmechanismen der Therapie mit Psychedelika

Ermittlung eines therapeutischen Referenzbereiches für Escitalopram

Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: results of the COMBINE-study

Identifying differential predictors for treatment response to amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia: results of the COMBINE-study

Measuring psychotherapeutic processes in the context of psychedelic experiences: Validation of the General Change Mechanisms Questionnaire (GCMQ)

Therapeutic reference range for olanzapine in schizophrenia revised

Low Escitalopram Concentrations in Patients with Depression predict Treatment Failure: A Naturalistic Retrospective Study

Functional connectivity signatures of NMDAR dysfunction in schizophrenia—integrating findings from imaging genetics and pharmaco-fMRI

How to find and validate therapeutic reference ranges for psychotropic drugs

Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorder

Therapeutic Reference Range for Aripiprazole in Schizophrenia Revised: a Systematic Review and Metaanalysis

Einstellungen von Expertinnen und Experten für psychische Gesundheit gegenüber Psilocybin

Correction to: Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia

Sind Psychedelika schnell wirksame Antidepressiva?

Correction: An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill patients with schizophrenia in Germany (COMBINE): a double-blind randomised controlled trial

How do we want to live? : we decide ourselves about our future

How Do We Want to Live? : We Decide Ourselves About Our Future

Is Therapeutic Drug Monitoring Relevant for Antidepressant Drug Therapy? Implications From a Systematic Review and Meta-Analysis With Focus on Moderating Factors

Psychopharmaka absetzen? Warum, wann und wie?

The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia

Therapeutic reference range for aripiprazole in schizophrenia revised: a systematic review and metaanalysis

Therapeutic reference range for aripiprazole in schizophrenia revised: a systematic review and metaanalysis

An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels

Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping

Pharmacokinetic Correlates of Once-Monthly Paliperidone Palmitate-Related Adverse Drug Reactions

The Potential Role of Psychedelic Drugs in Mental Health Care of the Future

Clinical response in patients treated with once-monthly paliperidone palmitate: analysis of a therapeutic drug monitoring (TDM) database

Prefrontal and striatal dopamine D2/D3 receptors correlate with fMRI BOLD activation during stopping

Psychopharmaka absetzen? Warum, wann und wie?

Assessment of Psychosocial Functioning in a Large Cohort of Patients with Schizophrenia

Lack of Smoking Effects on Pharmacokinetics of Oral Paliperidone-analysis of a Naturalistic Therapeutic Drug Monitoring Sample

Treatment Goals for Patients with Schizophrenia — A Narrative Review of Physician and Patient Perspectives

Wie wollen wir leben? : über unsere Zukunft entscheiden wir selbst

Wie wollen wir leben? : Über unsere Zukunft entscheiden wir selbst

A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design

Pharmacokinetics of venlafaxine in treatment responders and non-responders: a retrospective analysis of a large naturalistic database

Pharmacokinetic correlates of venlafaxine: associated adverse reactions

The Effects of Co-prescription of Pantoprazole on the Clozapine Metabolism

SPECT-Untersuchungen mit dem 123I-markierten Dopamintransporter-Liganden FP-CIT (DaTSCANTM) : DGN-Handlungsempfehlung (S1-Leitlinie)

Pocket Guide Psychopharmaka von A bis Z

Pocket Guide Psychopharmaka von A bis Z

Comprehensive Measurements of Intrauterine and Postnatal Exposure to Lamotrigine

Antidepressants in breast milk; comparative analysis of excretion ratios

The role of striatal dopamine D2/3 receptors in cognitive performance in drug-free patients with schizophrenia

Peripheral Oxytocin Predicts Higher-Level Social Cognition in Men Regardless of Empathy Quotient

Effects of the Proton Pump Inhibitors Omeprazole and Pantoprazole on the Cytochrome P450-Mediated Metabolism of Venlafaxine

Kompendium der psychiatrischen Pharmakotherapie

Kompendium der Psychiatrischen Pharmakotherapie

Pocket Guide Psychopharmaka von A bis Z

Pocket Guide Psychopharmaka von A bis Z

Clinical response in a risperidone-medicated naturalistic sample: patients’ characteristics and dose-dependent pharmacokinetic patterns

Präferenz von Zielparametern bei der Behandlung der Depression : Ergebnisse einer Delphi-Panel-Erhebung

Pharmacokinetic patterns of risperidone-associated adverse drug reactions

Dorsch – Lexikon der Psychotherapie und Psychopharmakotherapie

Molecular Imaging in the Clinical Neurosciences

Kompendium der psychiatrischen Pharmakotherapie

Kompendium der Psychiatrischen Pharmakotherapie

Pocket Guide Psychopharmaka von A bis Z